Last Updated: August 8, 2026

THYQUIDITY Drug Patent Profile

Name: THYQUIDITY Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Thyquidity patents expire, and what generic alternatives are available?

Thyquidity is a drug marketed by Stevens J and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has eleven patent family members in eleven countries.

The generic ingredient in THYQUIDITY is levothyroxine sodium. There are ten drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Thyquidity

A generic version of THYQUIDITY was approved as levothyroxine sodium by MYLAN on June 5^th, 2002.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for THYQUIDITY?
What are the global sales for THYQUIDITY?
What is Average Wholesale Price for THYQUIDITY?

Summary for THYQUIDITY

International Patents:	11
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	54
Patent Applications:	2,577
Drug Prices:	Drug price information for THYQUIDITY
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for THYQUIDITY
What excipients (inactive ingredients) are in THYQUIDITY?	THYQUIDITY excipients list
DailyMed Link:	THYQUIDITY at DailyMed

Drug patent expirations by year for THYQUIDITY

Pharmacology for THYQUIDITY

Drug Class	l-Thyroxine

Paragraph IV (Patent) Challenges for THYQUIDITY

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
THYQUIDITY	Oral Solution	levothyroxine sodium	100 mcg/5 mL	214047	1	2022-12-28

US Patents and Regulatory Information for THYQUIDITY

THYQUIDITY is protected by one US patents.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Stevens J	THYQUIDITY	levothyroxine sodium	SOLUTION;ORAL	214047-001	Nov 30, 2020		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for THYQUIDITY

See the table below for patents covering THYQUIDITY around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Cyprus	1117151		⤷ Start Trial
Denmark	2683361		⤷ Start Trial
European Patent Office	2683361	MÉTHODE DE MANUFACTURE D'UNE SOLUTION DE LÉVOTHYROXINE (METHOD FOR THE PREPARATON OF A LEVOTHYROXINE SOLUTION)	⤷ Start Trial
Spain	2559818		⤷ Start Trial
Croatia	P20151421		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.